Stereotaxis, Inc. (STXS) news stock charts
Stereotaxis, Inc. (STXS) Investment Summary:
This annual report on Form 10-K, including the sections entitled “Business” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contains forward-looking statements. These statements relate to, among other things: • our business strategy; • our value proposition; • the timing and status of review by our collaboration partner of manufacturing and design issues relating to our magnetic irrigated catheter; • the timing and prospects for regulatory approval of our additional disposable interventional devices; • our estimates regarding our capital requirements; • the ability of physicians to perform certain medical procedures with our products safely, effectively and efficiently; ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2008%2f03%2f17%2f0001193125-08-058487.html#FIS_BUSINESS"STEREOTAXIS INC (STXS:NASDAQ)
Snapshot of STEREOTAXIS INC (STXS)
|
OPEN
$5.15
|
PREVIOUS CLOSE
$5.16
|
|
|
DAY HIGH
$5.22
|
DAY LOW
$4.95
|
|
|
52 WEEK HIGH
03/9/10 - $6.02
|
52 WEEK LOW
04/14/09 - $2.98
|
|
|
MARKET CAP
251.5M
|
AVERAGE VOLUME 10 D
349.1K
|
|
|
EPS TTM
$-0.62
|
SHARES OUTSTANDING
50.3M
|
|
|
STXS Does Not Pay Dividends
|
P/E TTM
--
|
|
| K = Thousands M = Millions B = Billions | ||
related news
Key developments for STEREOTAXIS INC (STXS)
Stereotaxis Inc. expected to Report Q1 2010 Results on May 7, 2010. This event was calculated by Capital IQ (Created on February 25, 2010).
Stereotaxis Inc. reported unaudited earnings results for the fourth quarter and full year ended December 31, 2009. For the quarter, the company's revenue grew 16% to $14.1 million compared with $12.1 million in the same quarter a year ago. The company's operating loss decreased 9% to $5.8 million compared with $6.4 million in the prior year. The company reported a net loss of $6.7 million, or $0.14 per basic and diluted share. This compared with a net loss for the fourth quarter of 2008 of $7.5 million, or $0.20 per basic and diluted share. For the full year, revenue grew 27% to $51.1 million compared with $40.4 million in 2008. Net loss was $27.5 million or $0.63 per basic and diluted share compared to net loss of $43.9 million or $1.20 per basic and diluted share for the previous year. Operating loss was $23.8 million compared to 441 million for the previous year. The company provided earnings guidance for the full year 2010. For the year, the company expects its total revenue growth in the mid to 20% range and gross margins above 65%.
Stereotaxis anticipated that hospital budgets for capital expenditures will improve during 2010, resulting in growing customer orders.
Stereotaxis, Inc. financial resources
STXS Competitors
| Company | Last | Change |
| Endologix Inc | $3.63 USD | -0.01 |
| Micrus Endovascular Corp | $20.11 USD | +0.27 |
| Staar Surgical Co | $3.70 USD | +0.02 |
| Synergetics USA Inc | $1.46 USD | +0.02 |
| Vascular Solutions Inc | $9.14 USD | -0.08 |
| Market data is delayed at least 15 minutes. | ||
Industry Analysis
| Valuation | STXS | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 4.9x |
|
| Price/Book | 33.9x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 4.0x |
|
|
STXS |
||
STXS transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent Financial News About Stereotaxis, Inc.
Stereotaxis Reports 16% Revenue Increase in the Fourth Quarter 2009
Read article
Stereotaxis, Inc. Q4 2009 Earnings Call Transcript
Read article
Stereotaxis Reports 16% Revenue Increase in the Fourth Quarter 2009
Read article
STEREOTAXIS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
Read article
Stereotaxis Announces Fourth Quarter 2009 Earnings Release Date and Conference Call
Read article
STEREOTAXIS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Read article
Stereotaxis Announces Fourth Quarter 2009 Earnings Release Date and Conference Call
Read article
STEREOTAXIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Read article
STEREOTAXIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Read article
Stereotaxis Reports 26% Third Quarter 2009 Revenue Growth
Read article
STEREOTAXIS, INC. Files SEC form 8-K, Results of Operations and Financial Condition
Read article
Stereotaxis CCO to retire
Read article
STEREOTAXIS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Read article
STEREOTAXIS, INC. Files SEC form 8-K, Other Events
Read article